Subsequently, researchers speculated that tsRNA-5008a may have the ability to regulate ferroptosis, and they found that ferroptosis might be markedly inhibited by tsRNA-5008a knockdown, which targets SLC7A11 (a ferroptosis-related indicator) through AGO2, thereby reducing AF in vivo and in vitro. This evidence concerns the gene AGO2 and atrial fibrillation.